Armata Pharmaceuticals, Inc.
General ticker "ARMP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $84.7M (TTM average)
Armata Pharmaceuticals, Inc. follows the US Stock Market performance with the rate: 38.7%.
Estimated limits based on current volatility of 7.0%: low 5.51$, high 6.33$
Factors to consider:
- Total employees count: 66 (-12.0%) as of 2023
- Top business risk factors: Insufficient funding, Product liability, Controlled company status, Cybersecurity threats, Climate change and natural disasters
- Current price 79.8% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.15$, 3.30$]
- 2025-12-31 to 2026-12-31 estimated range: [0.83$, 2.47$]
Financial Metrics affecting the ARMP estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -52.68 <= 0.33
- Positive: -4.48 < Investing cash flow per share per price, % of -2.64
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term ARMP quotes
Long-term ARMP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $5.51MM | $4.53MM | $5.17MM |
| Operating Expenses | $42.45MM | $45.42MM | $47.61MM |
| Operating Income | $-36.95MM | $-40.89MM | $-42.44MM |
| Non-Operating Income | $0.06MM | $-28.16MM | $23.52MM |
| R&D Expense | $35.02MM | $33.77MM | $34.43MM |
| Income(Loss) | $-36.89MM | $-69.05MM | $-18.92MM |
| Profit(Loss)* | $-36.92MM | $-69.05MM | $-18.92MM |
| Stockholders Equity | $36.08MM | $-32.06MM | $-48.02MM |
| Assets | $95.83MM | $98.36MM | $86.44MM |
| Operating Cash Flow | $-32.48MM | $-47.42MM | $-37.55MM |
| Capital expenditure | $2.21MM | $8.14MM | $1.88MM |
| Investing Cash Flow | $-2.21MM | $-8.13MM | $-1.88MM |
| Financing Cash Flow | $44.02MM | $53.99MM | $34.96MM |
| Earnings Per Share** | $-1.08 | $-1.91 | $-0.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.